Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

VVOS

Vivos Therapeutics Inc

Oct 11 • 04:00PM ET

2.53

Dollar change +0.22
Percentage change 9.52	%

Healthcare • Medical Devices • USA • NASD

Peers: ALGN GMED HSIC MMSI NVST PDCO SMLR STAA XRAY ZYXI

| Held by: VXF DFAC DFSU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.30	Insider Own	12.88%	Shs Outstand	4.77M	Perf Week	0.80%
Market Cap	12.07M	Forward P/E	-	EPS next Y	-1.51	Insider Trans	0.00%	Shs Float	4.28M	Perf Month	-11.54%
Income	-12.04M	PEG	-	EPS next Q	-0.66	Inst Own	3.92%	Short Float	2.19%	Perf Quarter	-8.33%
Sales	14.02M	P/S	0.86	EPS this Y	74.51%	Inst Trans	-22.82%	Short Ratio	0.07	Perf Half Y	-4.17%
Book/sh	1.87	P/B	1.36	EPS next Y	46.83%	ROA	-81.41%	Short Interest	0.09M	Perf Year	-67.77%
Cash/sh	1.45	P/C	1.75	EPS next 5Y	-	ROE	-284.99%	52W Range	1.91 - 48.79	Perf YTD	-79.66%
Dividend Est.	-	P/FCF	-	EPS past 5Y	3.00%	ROI	-157.93%	52W High	-94.81%	Beta	7.70
Dividend TTM	-	Quick Ratio	1.18	Sales past 5Y	45.07%	Gross Margin	55.87%	52W Low	32.46%	ATR (14)	0.32
Dividend Ex-Date	-	Current Ratio	1.18	EPS Y/Y TTM	67.45%	Oper. Margin	-96.23%	RSI (14)	46.81	Volatility	7.74% 13.80%
Employees	114	Debt/Eq	0.28	Sales Y/Y TTM	-9.23%	Profit Margin	-85.90%	Recom	1.00	Target Price	7.42
Option/Short	No / Yes	LT Debt/Eq	0.20	EPS Q/Q	87.05%	Payout	-	Rel Volume	0.06	Prev Close	2.31
Sales Surprise	12.61%	EPS Surprise	42.86%	Sales Q/Q	19.41%	Earnings	Aug 14 AMC	Avg Volume	1.32M	Price	2.53
SMA20	-9.12%	SMA50	-4.61%	SMA200	-32.03%	Trades		Volume	85,308	Change	9.52%

Oct-08-24 07:30AM	Vivos Therapeutics Granted CPT Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association (GlobeNewswire)
Sep-19-24 07:00AM	Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -22.03%
Sep-18-24 10:05AM	Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children (Benzinga) +47.50%
07:00AM	Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring (GlobeNewswire)
Aug-14-24 04:05PM	Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) -5.11%
07:30AM	Loading…
07:30AM	Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Jul-01-24 12:33PM	Vivos eyes human trials for radiation treatment gel with IDE submission (Clinical Trials Arena) +6.31%
Jun-27-24 07:30AM	Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model (GlobeNewswire) +9.63%
Jun-12-24 07:30AM	Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance (GlobeNewswire) -8.24%
May-20-24 01:04PM	Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote FOR Re-Election of Its Highly Qualified Directors (GlobeNewswire)
May-15-24 01:01PM	Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -12.45%
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-14-24 04:05PM	Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) +23.88%
07:30AM	Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Apr-09-24 02:45PM	Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices (News Direct) -9.08%
08:53AM	Loading…
08:53AM	Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today? (InvestorPlace)
07:30AM	Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement (GlobeNewswire)
Apr-01-24 12:53PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.23%
Mar-28-24 08:53PM	VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
07:30AM	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call (GlobeNewswire)
Feb-22-24 12:39PM	3 Stocks to Turn $1,000 Into $1 Million: February 2024 (InvestorPlace)
Feb-15-24 08:00AM	Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds (GlobeNewswire) +6.14%
Feb-12-24 09:24AM	Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions (News Direct)
Feb-06-24 07:30AM	Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities (GlobeNewswire)
Jan-08-24 07:30AM	Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA (GlobeNewswire)
Dec-11-23 07:30AM	Vivos Therapeutics Presents Groundbreaking Event: Empowering Women to Champion Airway (GlobeNewswire) -14.44%
Nov-30-23 08:51AM	Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today? (InvestorPlace) -40.24%
01:20AM	Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea (MedTech Dive)
Nov-29-23 01:04PM	Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea (News Direct) +833.94%
11:56AM	Loading…
11:56AM	Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today? (InvestorPlace)
08:07AM	UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea (Reuters)
07:39AM	US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (Reuters)
07:30AM	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea (GlobeNewswire)
Nov-14-23 04:05PM	Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +9.71%
Nov-09-23 04:30PM	Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call (GlobeNewswire) -11.55% -5.84%
Nov-03-23 01:51PM	Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare (News Direct) -5.52%
Nov-02-23 05:00PM	Vivos Therapeutics Closes $4 Million Private Placement (GlobeNewswire) +7.10%
Oct-31-23 08:00AM	Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -16.19%
Oct-26-23 07:30AM	Vivos Therapeutics Announces Reverse Stock Split (GlobeNewswire) -6.90%
Oct-24-23 07:30AM	Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare (GlobeNewswire) -5.76%
Oct-12-23 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS) (Zacks)
Oct-11-23 01:47PM	Vivos Therapeutics secures Middle East-North Africa distribution deal and Stanford study (News Direct)
07:30AM	Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine (GlobeNewswire)
Oct-05-23 07:30AM	Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion (GlobeNewswire) +6.90%
Oct-04-23 07:30AM	Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers (GlobeNewswire) +64.59%
Oct-02-23 07:30AM	New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference (GlobeNewswire)
Aug-23-23 09:55AM	Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher (Zacks)
Aug-16-23 04:05PM	Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.12% -7.05%
07:30AM	Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-14-23 05:06PM	Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-10-23 08:31PM	Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call (GlobeNewswire) +9.97%
Jun-15-23 12:55PM	Vivos Therapeutics highlights 1Q financial and operational growth with major acquisition (News Direct) +15.77%
Jun-13-23 08:50AM	Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS) (Zacks) +14.55%
Jun-10-23 04:31PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2023 Earnings Call Transcript (Insider Monkey)
Jun-09-23 01:04PM	Q1 2023 Vivos Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -10.17%
Jun-08-23 05:25PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +13.25%
04:05PM	Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jun-06-23 04:30PM	Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call (GlobeNewswire)
May-16-23 01:19PM	Vivos Therapeutics talks clinical study success of POD migraine treatment, new timeline for cashflow (News Direct) +9.09%
May-09-23 07:30AM	Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations (GlobeNewswire)
May-01-23 04:09PM	A Headache-Free Future? Vivos' POD Device Slashes Migraine Symptoms by 89% in Clinical Study (Benzinga)
07:30AM	Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos POD® Appliance Treatment (GlobeNewswire)
Apr-05-23 06:36AM	The Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analyst Just Cut Their Revenue Forecast By 14% (Simply Wall St.)
Apr-04-23 12:30PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update (GlobeNewswire) +8.99% -5.25%
07:30AM	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call (GlobeNewswire)
Mar-08-23 07:30AM	Vivos Therapeutics to Participate in Fireside Chat at the 35th Annual ROTH Conference (GlobeNewswire) -5.11%
Mar-01-23 07:30AM	Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LLC (GlobeNewswire) -27.87%
Feb-21-23 04:05PM	Vivos Therapeutics to Present at the Emerging Growth Conference on February 22, 2023 (GlobeNewswire) -5.70%
07:00AM	Presenting on the Emerging Growth Conference on February 22 Register Now (GlobeNewswire)
Jan-27-23 07:05AM	7 Micro-Cap Stocks to Buy for Risk-Taking Investors (InvestorPlace)
Jan-20-23 07:30AM	Vivos Therapeutics Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -9.33%
Jan-09-23 04:45PM	Vivos Therapeutics Closes $8 Million Private Placement (GlobeNewswire) -5.88% +5.56%
Jan-05-23 08:10AM	Vivos Therapeutics Announces Pricing of $8 Million Private Placement (GlobeNewswire)
Jan-04-23 07:30AM	Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA Oral Appliance for Treatment of Obstructive Sleep Apnea (GlobeNewswire) +154.05%
Dec-20-22 04:15PM	Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update (GlobeNewswire) +14.13% -22.64%
Dec-16-22 07:30AM	Vivos Therapeutics Schedules Release of Second and Third Quarter 2022 Financial Results and Conference Call (GlobeNewswire) +5.14%
Dec-15-22 07:30AM	Vivos Therapeutics Announces New Revenue Stream Through Strategic Medical Billing Relationship with Nexus Dental Systems (GlobeNewswire)
Nov-28-22 04:47PM	Vivos Therapeutics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Third Quarter 2022 Quarterly Report on Form 10-Q (GlobeNewswire) -8.66%
Nov-27-22 07:49AM	Vivos Therapeutics First Quarter 2022 Earnings: Revenues Disappoint (Simply Wall St.)
Nov-22-22 07:30AM	Vivos Therapeutics Provides Update on Revenue Recognition Review (GlobeNewswire) +9.69%
Aug-26-22 07:30AM	Vivos Therapeutics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire)
Aug-22-22 04:05PM	Vivos Therapeutics Provides Update on Second Quarter Earnings Delay (GlobeNewswire)
Aug-15-22 07:30AM	Vivos Therapeutics to Reschedule Second Quarter 2022 Financial Results Conference Call (GlobeNewswire) +6.02%
Aug-09-22 08:00AM	Vivos Therapeutics Schedules Second Quarter 2022 Financial Results Conference Call (GlobeNewswire) -6.92%
Jul-14-22 08:00AM	Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances (Business Wire)
Jun-29-22 08:00AM	Vivos Therapeutics Announces Exclusive Distribution Agreement with GM Instruments, Ltd. for the U.S. and Canada (GlobeNewswire)
Jun-14-22 08:30AM	Vivos Therapeutics SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea (GlobeNewswire) -11.11%
May-26-22 08:00AM	Vivos Therapeutics to Present at Upcoming SLEEP 2022 Annual Meeting (GlobeNewswire) +6.08%
May-21-22 08:35AM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Just Slashed This Year's Estimates (Simply Wall St.)
May-16-22 04:05PM	Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update (GlobeNewswire) +13.33%
Apr-28-22 07:30AM	Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Apr-26-22 08:26AM	Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method (GlobeNewswire)
Mar-31-22 04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update (GlobeNewswire) -18.66%
08:14AM	Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call (GlobeNewswire)
Mar-08-22 09:11AM	Fast Company Selects Vivos Therapeutics for 2022 Worlds Most Innovative Companies List (GlobeNewswire) -10.75%
Mar-03-22 08:00AM	Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders (GlobeNewswire) -7.44%
Mar-02-22 08:00AM	Vivos Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-24-22 08:00AM	Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome (GlobeNewswire) +8.87%

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VVOS

Vivos Therapeutics Inc

Upgrade your FINVIZ experience